Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2025-12-24 @ 4:21 PM
NCT ID:
NCT00774566
Eligibility Criteria:
Inclusion Criteria:
* Documented paroxysmal PAF: PAF diagnosis, 2 episodes of PAF within the last 3 months, at least 1 episode of PAF must be documented.
* Age 18-75
* Documented effectiveness failure of at least 1 AAD including beta-blockers
Exclusion Criteria:
* AAD usage \< 3 half life periods (except beta-blocker)
* LA size \> 55 mm
* LA thrombus
* Previous LA ablation/surgery, structural heart disease, heart failure class III-IV
* Hypertrophic cardiomyopathy
* Mitral prosthesis
* Unstable angina
* Uncontrolled hyperthyroidism
* Stroke or TIA within 6 months
* Myocardial infarction within 2 months
* Cardiac surgery within 3 months
* Thrombocytosis, thrombocytopenia
* Any condition contraindicating chronic anticoagulation
* EF \< 40%
* Pregnancy
* Life expectancy \< 1 year
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00774566
Study Brief:
Protocol Section:
NCT00774566